openPR Logo
Press release

Transdermal Drug Delivery Systems Market Size to Surpass USD 87.32 Bn by 2030 at Sustained CAGR of 4.9%

05-31-2023 01:47 PM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
Transdermal Drug Delivery Systems Market

Transdermal Drug Delivery Systems Market

According to a new Allied Market Research Reports study, the global transdermal drug delivery systems market generated $52.47 billion in 2020, and is expected to reach $87.32 billion by 2030, growing at a CAGR of 4.9% from 2021 to 2030. The study analyzes the important strategies, drivers, competition, market dynamics, size, and important investment regions.

Request Sample Copy of the Report:

https://www.alliedmarketresearch.com/request-sample/485

Key Takeaways:

Transdermal drug delivery systems are medical patches that deliver drugs through the skin to treat various conditions such as pain, hypertension, and hormonal imbalances.

The market is segmented based on type, application, and region. By type, the market is classified into matrix patches, reservoir patches, and others. By application, the market is categorized into pain management, hormone replacement therapy, cardiovascular diseases, neurological disorders, and others.

North America dominates the market due to the high prevalence of chronic diseases, the presence of major pharmaceutical companies, and the availability of advanced healthcare infrastructure.

Market Drivers:

Rising prevalence of chronic diseases: The growing prevalence of chronic diseases such as diabetes, cardiovascular diseases, and cancer is one of the major drivers of the transdermal drug delivery systems market. These medical patches are often used to deliver drugs for pain management, hormone replacement therapy, and other chronic conditions.

Advantages of transdermal drug delivery systems: Transdermal drug delivery systems offer several advantages over other drug delivery methods, including improved patient compliance, better pharmacokinetics, reduced side effects, and improved efficacy.

Growing geriatric population: The aging population is a key driver of the transdermal drug delivery systems market, as older adults are more likely to suffer from chronic conditions and may prefer non-invasive drug delivery methods.

Market Segmentation:

Type: The market can be segmented into matrix patches, reservoir patches, and others. Matrix patches are the most commonly used type of transdermal drug delivery systems and are used to deliver drugs that are soluble in the adhesive layer. Reservoir patches have a separate drug reservoir and adhesive layer, allowing for the delivery of a wider range of drugs.

Application: The market can be segmented into pain management, hormone replacement therapy, cardiovascular diseases, neurological disorders, and others. Pain management is the largest application segment, accounting for a significant share of the market due to the high prevalence of chronic pain conditions. Hormone replacement therapy is another significant application segment due to the high demand for transdermal patches for the treatment of menopause-related symptoms.

Region: The market can be segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America is the largest regional market, followed by Europe and Asia-Pacific. The high prevalence of chronic diseases, increasing geriatric population, and advanced healthcare infrastructure are driving the growth of the market in these regions.

End-user: The market can be segmented into hospitals & clinics, home care settings, and others. Hospitals & clinics are the largest end-user segment due to the high demand for transdermal drug delivery systems in the treatment of chronic diseases.

Request for Customization -

https://www.alliedmarketresearch.com/request-for-customization/485

Competitive Landscape:

3M Company
Novartis International AG
Johnson & Johnson Services, Inc.
Mylan N.V.
Bayer AG
Boehringer Ingelheim International GmbH
GlaxoSmithKline plc
Hisamitsu Pharmaceutical Co., Inc.
Teva Pharmaceutical Industries Ltd.
UCB S.A.

Buy this Premium Research Report:

https://www.alliedmarketresearch.com/purchase-enquiry/485

VALUE PROPOSITIONS RELATED TO THE REPORT:

Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
Comprehensive quantitative and qualitative insights at segment and sub-segment level
Covid 19 impact trends and perspective
Granular insights at global/regional/country level
Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
Blanket coverage on competitive landscape

Browse more latest healthcare reports:

Analgesics Market https://www.alliedmarketresearch.com/analgesics-market

ENT Disorder Treatment Market https://www.alliedmarketresearch.com/ent-disorder-treatment-market

Blood Stream Infection Testing Market https://www.alliedmarketresearch.com/blood-stream-infection-testing-market

Operating Room Management Market https://www.alliedmarketresearch.com/operating-room-management-market

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Transdermal Drug Delivery Systems Market Size to Surpass USD 87.32 Bn by 2030 at Sustained CAGR of 4.9% here

News-ID: 3073527 • Views:

More Releases from Allied Market Research

Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices. Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529 What Are Urinary Drainage Bags? Urinary drainage bags are specialized medical devices designed to collect
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031. The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growth
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Billion by 2030; Growing at a CAGR of 17.2%
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil …
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario. Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strict
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of 5.6%
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of …
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031. Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise in

All 5 Releases


More Releases for Transdermal

Transdermal Skin Patches: Market Trends and Forecast
The transdermal skin patches market size has grown steadily in recent years. It will grow from $7.36 billion in 2023 to $7.67 billion in 2024 at a compound annual growth rate (CAGR) of 4.2%. The growth in the historic period can be attributed to increasing incidence of cardiovascular diseases, strong economic growth in emerging markets, the increase in pharmaceutical r&d expenditure and increased healthcare expenditure. The transdermal skin patches
Global Transdermal Drug Delivery Systems Market 2023 Industry Data - Transdermal …
Global Transdermal Drug Delivery Systems market report by The Brainy Insights provides readers with a descriptive outlook of the market at regional as well as country levels. The historical data in the report provides an accurate analysis of the market in the forecast period (2023-2032). Market was studied in-depth to provide an overview of the market by value chain analysis and SWOT analysis. The study was done by doing a qualitative and
Global Transdermal Skin Patches Market | Global Transdermal Skin Patches Industr …
The transdermal skin patches market comprises of sales of transdermal skin patches products and connected services utilize to deliver medicine to the human body through patches. The Transdermal skin patches comprise the usage of adhesive patches made up of polymers that comprises drugs. The drug from such patches are absorbed into the body and ultimately into the blood stream disregarding the drug delivery through pill, or injections. According to the
Transdermal Patch Market Report 2018: Segmentation by Product (Fentanyl Transder …
Global Transdermal Patch market research report provides company profile for Actavis, Mundipharma, Henan Lingrui Pharmaceutical, Changzhou Siyao, Rfl Pharmaceutical, Hisamitsu Pharmaceutical, Novartis, Johnson & Johnson, Teikoku Pharma, Mylan and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018
US Transdermal Patch Market US Transdermal Sales Report 2020
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Transdermal Patch 2. Classification of Transdermal Patches 2.1 Single/ Multiple-Layer Drug-in-Adhesive 2.2 Reservoir Transdermal Patches 2.3 Matrix Based Transdermal Patches 2.4 Vapor Patch 2.5 Active and Passive Patch 3. Why There Exist Need for Transdermal Patches? 4. Mechanism of Transdermal Patch Drug Delivery 4.1 Properties of Transdermal Therapeutics 4.2 Components of
Transdermal Patch Market Transdermal Patch Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Introduction to Transdermal Patch Classification of Transdermal Patches 2.1 Single/ Multiple-Layer Drug-in-Adhesive 2.2 Reservoir Transdermal Patches 2.3 Matrix Based Transdermal Patches 2.4 Vapor Patch 2.5 Active and Passive Patch Why There Exist Need for Transdermal Patches? Mechanism of Transdermal Patch Drug Delivery 4.1 Properties of Transdermal Therapeutics 4.2 Components of Transdermal Patch 4.3